https://www.openbell.ai/ 2026-10-16T14:42:01.198Z hourly 1.0 https://www.openbell.ai/support 2026-10-16T14:42:01.198Z monthly 0.7 https://www.openbell.ai/privacy 2026-10-16T14:42:01.198Z monthly 0.5 https://www.openbell.ai/terms 2026-10-16T14:42:01.198Z monthly 0.5 https://www.openbell.ai/feed.json 2026-10-16T14:42:01.198Z hourly 0.8 https://www.openbell.ai/news/SHOP:1792161702326 2026-10-16T14:41:42.326Z daily 0.9 https://cdn.brandfetch.io/SHOP/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Maintains Outperform on Shopify, Raises Price Target to C$200 RBC Capital analyst Paul Treiber has maintained an Outperform rating on Shopify (TSX: SHOP) and increased the price target from C$180 to C$200. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/PVLA:1792161652409 2026-10-16T14:40:52.409Z daily 0.9 https://cdn.brandfetch.io/PVLA/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Palvella Therapeutics with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Palvella Therapeutics (NASDAQ: PVLA) with an Outperform rating. This marks a significant endorsement for the company as it seeks to enhance its market presence. https://www.openbell.ai/news/SHOP:1792161627985 2026-10-16T14:40:27.985Z daily 0.9 https://cdn.brandfetch.io/SHOP/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Maintains Outperform on Shopify, Raises Price Target to $200 RBC Capital analyst Paul Treiber has maintained an 'Outperform' rating on Shopify (NASDAQ: SHOP) and increased the price target from $180 to $200. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/WVE:1792161540570 2026-10-16T14:39:00.570Z daily 0.9 https://cdn.brandfetch.io/WVE/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Wave Life Sciences with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Wave Life Sciences (NASDAQ: WVE) with an Outperform rating. This marks a positive outlook for the company as it enters a new phase of market evaluation. https://www.openbell.ai/news/EIDO:1792161486574 2026-10-16T14:38:06.574Z daily 0.9 https://cdn.brandfetch.io/EIDO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of U.S.-listed Indonesian companies are trading lower after the MSCI announced the launch of a consultation on a proposal to reclassify the MSCI Indonesia Indexes from Emerging Market to Standalone Market status. openbell Financial News https://www.openbell.ai/news/NUE:1792161450176 2026-10-16T14:37:30.176Z daily 0.9 https://cdn.brandfetch.io/NUE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of steelmakers are trading higher as U.S. steel prices reach a four-year high due to import tariffs. Also, reports suggesting that U.S. Commerce Secretary Lutnick is refusing to give concessions to Mexican steel imports may also be bolstering expectations that protectionism will aid pricing power and margin expansion. openbell Financial News https://www.openbell.ai/news/RYTM:1792161393620 2026-10-16T14:36:33.620Z daily 0.9 https://cdn.brandfetch.io/RYTM/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Rhythm Pharmaceuticals with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Rhythm Pharmaceuticals (NASDAQ: RYTM) with an Outperform rating. This marks a positive outlook for the company in the market. https://www.openbell.ai/news/TCXB:1792161300480 2026-10-16T14:35:00.480Z daily 0.9 https://cdn.brandfetch.io/TCXB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Trading Halt: Halt status updated at 10:35:00 AM ET: Quotation Resumption: IPO security released for quotation openbell Financial News https://www.openbell.ai/news/FTH:1792161103224 2026-10-16T14:31:43.224Z daily 0.9 https://cdn.brandfetch.io/FTH/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Faeth Therapeutics with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Faeth Therapeutics (NASDAQ: FTH) with an Outperform rating. This marks a significant endorsement for the company in the financial markets. https://www.openbell.ai/news/STX:1792161048309 2026-10-16T14:30:48.309Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Seagate-Technology-Logo-And-Sign.jpg?width=250&height=187 Seagate, Western Digital Face Supply Risks as AI Demand Drives Capacity Expansion Seagate Technology Holdings Plc. (NASDAQ: STX) and Western Digital Corp. (NASDAQ: WDC) are experiencing stock declines due to investor concerns over supply growth and financing risks related to AI infrastructure expansion. Both companies have seen their stocks drop approximately 5% recently, despite being up 110% to 150% in 2026. Increased competition, particularly from Toshiba's plans to double HDD manufacturing capacity by 2027, has raised pricing concerns, while Wall Street firms like UBS have lowered price forecasts amid scrutiny of supply-demand conditions. https://www.openbell.ai/news/NBIS:1792161043080 2026-10-16T14:30:43.080Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Nebius-Group.jpg?width=250&height=187 Why Is Nebius Group Stock Falling Friday? Nebius Group N.V. (NASDAQ: NBIS) stock fell nearly 6% on Friday, trading at $177.29, amid concerns over artificial intelligence infrastructure spending following a Gartner warning that over 80% of neocloud providers may cease independent operations by 2030. The broader technology sector is also experiencing selling pressure, with the Nasdaq down 0.83%. Nebius is expected to report a quarterly loss of 79 cents per share, with revenue projected to rise to $904.29 million from $146.10 million, while analysts maintain a Buy consensus rating with an average price target of $272.62. https://www.openbell.ai/news/RCUS:1792161003574 2026-10-16T14:30:03.574Z daily 0.9 https://cdn.brandfetch.io/RCUS/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Arcus Biosciences with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Arcus Biosciences (NYSE: RCUS) with an Outperform rating. This marks a positive outlook for the company in the market. https://www.openbell.ai/news/TSLA:1792160631912 2026-10-16T14:23:51.912Z daily 0.9 https://cdn.brandfetch.io/TSLA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Slovakia Approves Tesla Full Self-Driving System Slovakia has approved Tesla's Full Self-Driving system, marking a significant regulatory milestone for the company. This approval may enhance Tesla's competitive edge in the autonomous vehicle market. The stock ticker for Tesla is TSLA. https://www.openbell.ai/news/MBLY:1792160442758 2026-10-16T14:20:42.758Z daily 0.9 https://cdn.brandfetch.io/MBLY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Initiates Coverage On Mobileye Global with Buy Rating, Announces Price Target of $11 Citigroup analyst Michael Ward has initiated coverage on Mobileye Global (NASDAQ: MBLY) with a Buy rating. The firm has set a price target of $11 for the stock. https://www.openbell.ai/news/INDB:1792160379430 2026-10-16T14:19:39.430Z daily 0.9 https://cdn.brandfetch.io/INDB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Independent Bank Corp. shares are trading higher after the company reported better-than-expected Q3 financial results. openbell Financial News https://www.openbell.ai/news/NTRP:1792160360107 2026-10-16T14:19:20.107Z daily 0.9 https://cdn.brandfetch.io/NTRP/w/400/h/400?c=1idopYfmtR7ZKg8QMud NextTrip shares are trading lower after the company reported worse-than-expected Q2 financial results. openbell Financial News https://www.openbell.ai/news/OMER:1792160282793 2026-10-16T14:18:02.793Z daily 0.9 https://cdn.brandfetch.io/OMER/w/400/h/400?c=1idopYfmtR7ZKg8QMud Omeros shares are trading lower after the company announced that the EMA’s CHMP issued a negative opinion on its marketing authorization application for narsoplimab in TA-TMA, following re-examination of its original negative opinion adopted in June 2026. openbell Financial News https://www.openbell.ai/news/HAIN:1792160214742 2026-10-16T14:16:54.742Z daily 0.9 https://cdn.brandfetch.io/HAIN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Hain Celestial Group shares are trading lower following a report suggesting that the company is weighing a possible Chapter 11 bankruptcy filing. openbell Financial News https://www.openbell.ai/news/VRNS:1792160207603 2026-10-16T14:16:47.603Z daily 0.9 https://cdn.brandfetch.io/VRNS/w/400/h/400?c=1idopYfmtR7ZKg8QMud TD Cowen Downgrades Varonis Systems to Hold, Lowers Price Target to $49.75 TD Cowen analyst Shaul Eyal has downgraded Varonis Systems (NASDAQ: VRNS) from a Buy rating to Hold. The price target for the stock has also been reduced from $56 to $49.75. https://www.openbell.ai/news/CACI:1792160187430 2026-10-16T14:16:27.430Z daily 0.9 https://cdn.brandfetch.io/CACI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Macquarie Initiates Coverage On CACI International with Outperform Rating, Announces Price Target of $780 Macquarie analyst Marni Lysaght has initiated coverage on CACI International (NYSE: CACI) with an Outperform rating. The firm has set a price target of $780 for the company's stock. https://www.openbell.ai/news/SMTC:1792160088973 2026-10-16T14:14:48.973Z daily 0.9 https://cdn.brandfetch.io/SMTC/w/400/h/400?c=1idopYfmtR7ZKg8QMud TD Cowen Reiterates Buy on Semtech, Maintains $215 Price Target TD Cowen analyst Sean O'Loughlin has reiterated a Buy rating on Semtech (NASDAQ: SMTC) and maintained a price target of $215 for the stock. This endorsement suggests confidence in the company's future performance and potential for growth. https://www.openbell.ai/news/ACN:1792159996036 2026-10-16T14:13:16.036Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Warsaw--Poland---May-2020-Accenture-Comp.jpg?width=250&height=187 Accenture Analysts Raise Price Targets as AI Fuels Multi-Year Growth Plan Analysts have raised their price targets for Accenture plc (NYSE: ACN) following the company's multi-year growth plan presented at its Investor Day. TD Cowen's Bryan C. Bergin increased his target from $193 to $201, while Susquehanna's James Friedman raised his from $210 to $230. Accenture aims for mid-single-digit revenue growth through fiscal 2027 and 2028, accelerating to mid- to high-single-digit growth in fiscal 2029, with a target of at least $9.5 billion in free cash flow for fiscal 2029. https://www.openbell.ai/news/RHHBY:1792159988779 2026-10-16T14:13:08.779Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Eye-In-Close-Up-With-Light-Blue-Iris-Det.jpg?width=250&height=187 Roche Secures FDA Approval for First At-Home Thyroid Eye Disease Therapy Roche Holdings AG received FDA approval for Enspryng (satralizumab), the first at-home therapy for thyroid eye disease. The approval was based on the Phase 3 SatraGO trials, where Enspryng showed a 52.9% proptosis response rate compared to 23.4% for placebo, and a 60.7% reduction in double vision versus 25.8% in the control group. Following the announcement, Roche's stock price increased by 0.93% to $57.31. https://www.openbell.ai/news/SITC:1792159979012 2026-10-16T14:12:59.012Z daily 0.9 https://cdn.brandfetch.io/SITC/w/400/h/400?c=1idopYfmtR7ZKg8QMud SITE Centers shares are trading higher after the company announced a $3 per share special cash distribution and a plan to voluntarily delist from the New York Stock Exchange. openbell Financial News https://www.openbell.ai/news/LUNR:1792159970638 2026-10-16T14:12:50.638Z daily 0.9 https://cdn.brandfetch.io/LUNR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Macquarie Initiates Coverage On Intuitive Machines with Outperform Rating, Announces Price Target of $25 Macquarie analyst Marni Lysaght has initiated coverage on Intuitive Machines (NASDAQ: LUNR) with an Outperform rating. The firm has set a price target of $25 for the company's stock. https://www.openbell.ai/news/FTAI:1792159812178 2026-10-16T14:10:12.178Z daily 0.9 https://cdn.brandfetch.io/FTAI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Macquarie Initiates Coverage On FTAI Aviation with Outperform Rating, Announces Price Target of $305 Macquarie analyst Marni Lysaght has initiated coverage on FTAI Aviation (NASDAQ: FTAI) with an Outperform rating. The firm has set a price target of $305 for the company's stock. https://www.openbell.ai/news/LADR:1792159743475 2026-10-16T14:09:03.475Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Display-Of-Stock-Market-Quotes.jpg?width=250&height=187 Ladder Capital Posts Upbeat Q3 Earnings, Joins Alcoa, Hyster-Yale And Other Big Stocks Moving Higher On Friday Ladder Capital Corp (NYSE: LADR) reported third-quarter earnings of 35 cents per share, surpassing the analyst consensus estimate of 31 cents, and quarterly sales of $118.904 million, exceeding expectations of $79.433 million. Following the announcement, Ladder Capital shares rose 3.3% to $9.11. The overall U.S. stock market showed mixed results, with the Dow Jones gaining approximately 250 points on the same day. https://www.openbell.ai/news/MSTR:1792159686017 2026-10-16T14:08:06.017Z daily 0.9 https://cdn.brandfetch.io/MSTR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Strategy shares are trading lower after MSCI announced a review that may bar non-operating companies from inclusion in its indices from November 30. openbell Financial News https://www.openbell.ai/news/KTOS:1792159646885 2026-10-16T14:07:26.885Z daily 0.9 https://cdn.brandfetch.io/KTOS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Macquarie Initiates Coverage On Kratos Defense & Security with Outperform Rating, Announces Price Target of $70 Macquarie analyst Marni Lysaght has initiated coverage on Kratos Defense & Security (NASDAQ: KTOS) with an Outperform rating. The firm has set a price target of $70 for the company's stock. https://www.openbell.ai/news/SCHW:1792159529802 2026-10-16T14:05:29.802Z daily 0.9 https://cdn.brandfetch.io/SCHW/w/400/h/400?c=1idopYfmtR7ZKg8QMud TD Cowen Reiterates Buy on Charles Schwab, Maintains $129 Price Target TD Cowen analyst Bill Katz has reiterated a Buy rating on Charles Schwab (NYSE: SCHW) and has maintained a price target of $129 for the stock. This endorsement reflects confidence in the company's performance and market position. https://www.openbell.ai/news/GUTS:1792159483166 2026-10-16T14:04:43.166Z daily 0.9 https://cdn.brandfetch.io/GUTS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Fractyl Health Stock Is Sinking Friday Fractyl Health Inc. (NASDAQ: GUTS) experienced a nearly 50% drop in stock price on Friday, trading at $2.18, despite reporting positive six-month clinical trial results for its Revita weight-loss treatment. The decline is attributed to an investor class action lawsuit regarding earlier trial disclosures and concerns over the treatment's effectiveness. Morgan Stanley downgraded Fractyl from Overweight to Equal-weight and reduced its price forecast from $8 to $2, citing a decrease in the estimated probability of success for Revita and projected sales. https://www.openbell.ai/news/GUTS:1792159469502 2026-10-16T14:04:29.502Z daily 0.9 https://cdn.brandfetch.io/GUTS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Fractyl Health Stock Is Sinking Friday Fractyl Health Inc. (NASDAQ: GUTS) saw its stock price drop nearly 50% on Friday, trading at $2.18, despite reporting positive six-month clinical trial results for its Revita weight-loss treatment. The decline is attributed to an investor class action lawsuit alleging that the company misled investors about the treatment's effectiveness and issues with clinical site disclosures. Morgan Stanley downgraded Fractyl's stock from Overweight to Equal-weight and reduced its price forecast from $8 to $2, citing concerns over the treatment's prospects. https://www.openbell.ai/news/KRMN:1792159447567 2026-10-16T14:04:07.567Z daily 0.9 https://cdn.brandfetch.io/KRMN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Macquarie Initiates Coverage On Karman Holdings with Outperform Rating, Announces Price Target of $65 Macquarie analyst Marni Lysaght has initiated coverage on Karman Holdings (NYSE: KRMN) with an Outperform rating. The firm has set a price target of $65 for the company's stock. https://www.openbell.ai/news/GUTS:1792159407217 2026-10-16T14:03:27.217Z daily 0.9 https://cdn.brandfetch.io/GUTS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Fractyl Health Stock Is Sinking Friday Fractyl Health Inc. (NASDAQ: GUTS) saw its stock price plummet nearly 50% during trading on Friday, despite reporting positive six-month clinical trial results for its Revita weight-loss treatment. The decline is attributed to an investor class action lawsuit concerning earlier trial disclosures and doubts about the treatment's effectiveness. Following disappointing results from a previous report, Morgan Stanley downgraded the stock and reduced its price forecast from $8 to $2, leading to a significant drop in share value. https://www.openbell.ai/news/GUTS:1792159396748 2026-10-16T14:03:16.748Z daily 0.9 https://cdn.brandfetch.io/GUTS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Fractyl Health Stock Is Sinking Friday Fractyl Health Inc. (NASDAQ: GUTS) saw its stock price drop nearly 50% on Friday, trading at $2.11, despite reporting positive six-month clinical trial results for its Revita weight-loss treatment. The decline is attributed to an investor class action lawsuit regarding earlier trial disclosures and concerns about the treatment's effectiveness. Morgan Stanley downgraded the stock from Overweight to Equal-weight, reducing its price forecast from $8 to $2 and lowering the estimated probability of success for Revita from 50% to 35%. https://www.openbell.ai/news/GUTS:1792159362191 2026-10-16T14:02:42.191Z daily 0.9 https://cdn.brandfetch.io/GUTS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Fractyl Health Stock Is Sinking Friday Fractyl Health Inc. (NASDAQ: GUTS) saw its stock price drop nearly 50% during trading on Friday, despite reporting positive results from a six-month clinical trial of its Revita weight-loss treatment. The decline is attributed to an investor class action lawsuit regarding earlier trial disclosures and concerns over the treatment's effectiveness. Morgan Stanley downgraded the stock from Overweight to Equal-weight, reducing its price forecast from $8 to $2, following disappointing clinical results that led to a 68% drop in shares. https://www.openbell.ai/news/GUTS:1792159349694 2026-10-16T14:02:29.694Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Financial-Market-Crash-Concept-With-Red-.jpg?width=250&height=187 Why Fractyl Health Stock Is Sinking Friday Fractyl Health Inc. (NASDAQ: GUTS) saw its stock price drop nearly 50% in Friday's trading, despite reporting positive six-month clinical trial results for its Revita weight-loss treatment. The decline is attributed to an investor class action lawsuit concerning earlier trial disclosures and concerns over the treatment's effectiveness. Morgan Stanley downgraded the stock from Overweight to Equal-weight, reducing its price forecast from $8 to $2, and the shares were trading at $2.11 during premarket hours. https://www.openbell.ai/news/ABT:1792159329436 2026-10-16T14:02:09.436Z daily 0.9 https://cdn.brandfetch.io/ABT/w/400/h/400?c=1idopYfmtR7ZKg8QMud TD Cowen Reiterates Buy on Abbott Laboratories, Maintains $135 Price Target TD Cowen analyst Joshua Jennings has reiterated a Buy rating on Abbott Laboratories (NYSE: ABT) and has maintained a price target of $135 for the stock. This endorsement suggests confidence in the company's future performance. https://www.openbell.ai/news/AVAV:1792159309182 2026-10-16T14:01:49.182Z daily 0.9 https://cdn.brandfetch.io/AVAV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Macquarie Initiates Coverage On AeroVironment with Outperform Rating, Announces Price Target of $210 Macquarie analyst Marni Lysaght has initiated coverage on AeroVironment (NASDAQ: AVAV) with an Outperform rating. The firm has set a price target of $210 for the company's stock. https://www.openbell.ai/news/GUTS:1792159296504 2026-10-16T14:01:36.504Z daily 0.9 https://cdn.brandfetch.io/GUTS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Why Fractyl Health Stock Is Sinking Friday Fractyl Health Inc. (NASDAQ: GUTS) saw its stock price drop nearly 50% on Friday, trading at $2.11, following the announcement of positive six-month clinical trial results for its Revita weight-loss treatment. Despite achieving its co-primary endpoint in the REMAIN-1 trial, the company is facing an investor class action lawsuit over allegations of misleading disclosures regarding the treatment's effectiveness. Morgan Stanley downgraded Fractyl from Overweight to Equal-weight and reduced its price forecast from $8 to $2, citing concerns over the treatment's prospects. https://www.openbell.ai/news/MTB:1792158706121 2026-10-16T13:51:46.121Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Portland--Or--Usa---Mar-12--2020-Dow-Jon.jpg?width=250&height=187 Dow Surges 250 Points; M&T Bank Posts Upbeat Q3 Earnings The Dow Jones index increased by 250 points, or 0.48%, reaching 52,429.32, while the NASDAQ and S&P 500 experienced declines of 0.65% and 0.05%, respectively. M&T Bank reported third-quarter earnings of $5.08 per share, surpassing the analyst consensus estimate of $4.96, along with quarterly sales of $2.536 billion, exceeding expectations of $2.533 billion. In sector performance, energy shares rose by 1.4%, while information technology stocks fell by 1.1%. https://www.openbell.ai/news/REVB:1792158687713 2026-10-16T13:51:27.713Z daily 0.9 https://cdn.brandfetch.io/REVB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Revelation Biosciences shares are trading lower after the company announced a 1-for-7 reverse stock split, effective October 20. openbell Financial News https://www.openbell.ai/news/NVDA:1792158634181 2026-10-16T13:50:34.181Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Nvidia-office-building--Taipei--Taiwan.jpg?width=250&height=187 Nvidia GPUs Become Wall Street Collateral As AI Financing Expands Nvidia has established partnerships with six major financial institutions to create financing platforms aimed at mobilizing over $500 billion in third-party capital for AI infrastructure. This initiative allows lenders to use Nvidia's AI chips and compute contracts as collateral for credit, as demonstrated by CoreWeave's $8.5 billion GPU-backed loan and Lambda's recent loans totaling $1.926 billion. The financing model provides an alternative funding source for AI infrastructure, but it carries risks related to customer defaults and declining GPU values. https://www.openbell.ai/news/MBRX:1792158619800 2026-10-16T13:50:19.800Z daily 0.9 https://cdn.brandfetch.io/MBRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Moleculin Biotech shares are trading lower after the company announced a 1-for-20 reverse stock split, effective October 20. openbell Financial News https://www.openbell.ai/news/CTY:1792158600388 2026-10-16T13:50:00.388Z daily 0.9 https://cdn.brandfetch.io/CTY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Trading Halt: Halt status updated at 9:50:00 AM ET: Quotation Resumption: IPO security released for quotation openbell Financial News https://www.openbell.ai/news/QXL:1792158345316 2026-10-16T13:45:45.316Z daily 0.9 https://cdn.brandfetch.io/QXL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Quantum X Labs shares are trading higher after the company announced a LayerQake milestone, with validation on three IBM quantum processors meeting all predefined success criteria and substantially reducing computational errors. openbell Financial News https://www.openbell.ai/news/EMN:1792158260185 2026-10-16T13:44:20.185Z daily 0.9 https://cdn.brandfetch.io/EMN/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Downgrades Eastman Chemical to Neutral, Lowers Price Target to $66 JP Morgan analyst Jeffrey Zekaukas has downgraded Eastman Chemical (NYSE: EMN) from Overweight to Neutral. The price target for the stock has been reduced from $82 to $66. https://www.openbell.ai/news/ASTS:1792158170112 2026-10-16T13:42:50.112Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Los-Angeles--California---July-8-2025-As.jpg?width=250&height=187 Why Is AST SpaceMobile Stock Falling Friday? AST SpaceMobile Inc. (NASDAQ: ASTS) experienced a decline in stock price as investors took profits after a previous 5.51% rebound. The drop followed a downgrade by Piper Sandler analyst Alexander Potter, who reduced his rating from Overweight to Neutral and cut the price forecast from $98 to $54. Concerns were raised regarding delays in satellite deployments and increased competition from SpaceX, which is expanding its market presence. The stock was trading at $43.68, close to its 52-week low of $42.00. https://www.openbell.ai/news/DB:1792158069233 2026-10-16T13:41:09.233Z daily 0.9 https://cdn.brandfetch.io/DB/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Deutsche Bank prepares crypto custody launch, targets Asia growth' - Reuters Deutsche Bank is set to launch a crypto custody service as part of its strategy to expand in the Asian market. The initiative aims to cater to the growing demand for digital asset management in the region. This move aligns with the bank's broader efforts to enhance its offerings in the financial technology sector. https://www.openbell.ai/news/PRAX:1792157872971 2026-10-16T13:37:52.971Z daily 0.9 https://cdn.brandfetch.io/PRAX/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Initiates Coverage On Praxis Precision Medicine with Overweight Rating, Announces Price Target of $700 JP Morgan analyst Tessa Romero has initiated coverage on Praxis Precision Medicine (NASDAQ: PRAX) with an Overweight rating. The firm has set a price target of $700 for the stock.